Hims & Hers Health
HIMS
14.60
-1.42
-8.86%
Hims & Hers Health
US · HIMS
#1813 by market cap
Listed 1970
14.60
-1.42
-8.86%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Recent news
-
Company notice
Hims & Hers Health | 4: Statement of changes in beneficial ownership of securities-Officer Autor Deborah M.SEC · 2026/6/18
-
Hims & Hers Stock Extends Losses After Earnings Stumble -- Barrons.comBarron's · 2026/11/11
-
Rating change
A Quick Look at Today's Ratings for Hims & Hers Health(HIMS.US), With a Forecast Between $32 to $42Market Newswire · 2026/8/12
-
Rating change
J.P. Morgan Assigns Hims & Hers Stock a 'Hold' Rating. What's Behind the Cautious Stance?TipRanks · 2026/9/12
-
Rating change
BofA Securities Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Maintains Target Price $32Market Newswire · 2026/11/7
-
Rating change
Truist Financial Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Maintains Target Price $32Market Newswire · 2026/9/11
-
Rating change
Barclays Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Maintains Target Price $35Market Newswire · 2026/10/29
-
Company notice
Hims & Hers Health | 4: Statement of changes in beneficial ownership of securities-Director Cosgrove Delos M.SEC · 2026/6/16
-
A Quick Look at Today's Ratings for Hims & Hers Health(HIMS.US), With a Forecast Between $24 to $40Market Newswire · 2026/11/11
-
Rating change
Citi Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Maintains Target Price $33Market Newswire · 2026/8/13
-
Hims & Hers Health projects full-year revenue of $3.13 billion to $3.15 billion, below the estimated $3.21 billion.Gelonghui Finance · 2026/11/10
-
KeyBanc Maintains Hims & Hers Health(HIMS.US) With Hold RatingMarket Newswire · 2026/11/12
-
Rating change
J.P. Morgan Initiates Hims & Hers Health(HIMS.US) With Hold Rating, Announces Target Price $32Market Newswire · 2026/9/11
-
Company notice
8-K: Hims & Hers Health | 8-K: Hims & Hers Health, Inc. Reports First Quarter 2026 Financial ResultsSEC · 2026/5/12
-
Rating change
Truist Financial Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Announces Target Price $32Market Newswire · 2026/8/25
-
Company notice
Hims & Hers Health | 4: Statement of changes in beneficial ownership of securities-Officer Autor Deborah M.SEC · 2026/6/16
-
Company notice
Hims & Hers Health | 8-K: Hims & Hers Health, Inc. Reports Third Quarter 2026 Financial ResultsSEC · 2026/11/10
-
Rating change
Barclays Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Cuts Target Price to $35Market Newswire · 2026/8/21
-
Rating change
Jefferies Initiates Hims & Hers Health(HIMS.US) With Hold Rating, Announces Target Price $31Market Newswire · 2026/9/3
-
BofA Securities Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Maintains Target Price $32Market Newswire · 2026/10/29
-
Rating change
BofA Securities Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Cuts Target Price to $30Market Newswire · 2026/7/30
-
Company notice
Hims & Hers Health | 4: Statement of changes in beneficial ownership of securities-Officer Autor Deborah M.SEC · 2026/3/18
-
Without scientific evidence, it first went viral on social media: a loosening of regulations on peptide products—dubbed the "miracle drugs" of the bodybuilding community—has been sent to the White House for review, sending Hims & Hers shares up nearly 6% in a single day.Zhitong Finance · 2026/10/16
-
Rating change
KeyBanc Maintains Hims & Hers Health(HIMS.US) With Hold RatingMarket Newswire · 2026/9/2
-
Rating change
Truist Financial Maintains Hims & Hers Health(HIMS.US) With Hold RatingMarket Newswire · 2026/8/10
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 20:02:17 · For reference only, not investment advice and not tailored to your situation.
Hims & Hers Health discussion 0 comments